Affimed N.V. (AFMDQ) vs Onconetix, Inc. (ONCO)
- Affimed N.V. AFMDQ 0.00 NaN
- Onconetix, Inc. ONCO 0.48 −12.73%
Affimed N.V. and Onconetix, Inc. are both Biotechnology companies. Affimed N.V. and Onconetix, Inc. are of similar size ($2.9M and $2.8M). Affimed N.V. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. Onconetix, Inc. grew revenue faster over the last twelve months: −51.3% against −95.2%. Onconetix, Inc. has the higher net margin (−1,578.6% vs −7,834.6%) and the higher return on invested capital (−135.4% vs −13,558.8%). Across the 16 metrics below, Onconetix, Inc. leads on 12 and Affimed N.V. on 4.
Valuation
Profitability
| Metric | AFMDQ | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 80.38% | 65.16% |
| Operating margin | (7,858.63%) | (2,524.73%) | 0.00% |
| Net margin | (7,834.59%) | (1,578.60%) | 0.00% |
| Free cash flow margin | (8,603.91%) | (1,595.90%) | 0.00% |
| Return on equity | (148.64%) | (105.23%) | (56.36%) |
| Return on assets | (86.68%) | (57.37%) | (48.04%) |
| Return on invested capital | (13,558.83%) | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack